Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 3284 entries
View as:

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06519968 Org: User:
Start: 07/15/24 End: 12/27/24 Due: 12/27/25

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Phase: N/A Priority: Normal
NCT ID: NCT01462942 Org: User:
Start: 10/31/11 End: 01/31/13 Due: 01/31/14

Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01085123 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06034743 Org: User:
Start: 11/22/23 End: 10/13/25 Due: 10/13/26

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01020123 Org: User:
Start: 10/31/09 End: 02/28/11 Due: 02/28/12

To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden

Phase: N/A Priority: Normal
NCT ID: NCT00991419 Org: User:
Start: 02/28/10 End: 08/31/11 Due: 08/31/12

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Phase: N/A Priority: Normal
NCT ID: NCT05056727 Org: User:
Start: 09/30/21 End: 02/07/24 Due: 02/07/25

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04155645 Org: User:
Start: 11/21/19 End: 06/07/21 Due: 06/07/22

Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone

Phase: N/A Priority: Normal
NCT ID: NCT06457854 Org: User:
Start: 01/01/25 End: 02/04/25 Due: 02/04/26

Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg

Phase: N/A Priority: Normal
NCT ID: NCT01163630 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

EXACOS EG Population

Phase: N/A Priority: Normal
NCT ID: NCT06983340 Org: User:
Start: 05/15/25 End: 09/30/25 Due: 09/30/26

Epidemiology and Management of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01711502 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

OREIOS International Study

Phase: N/A Priority: Normal
NCT ID: NCT05239507 Org: User:
Start: 02/01/22 End: 03/12/23 Due: 03/12/24

Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02917057 Org: User:
Start: 08/01/15 End: 08/01/15 Due: 08/01/16

A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT01544179 Org: User:
Start: 03/15/12 End: 11/20/19 Due: 11/20/20

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Phase: N/A Priority: Normal
NCT ID: NCT00163488 Org: User:
Start: 01/31/05 End: 08/31/05 Due: 08/31/06

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00658021 Org: User:
Start: 05/30/08 End: 04/01/20 Due: 04/01/21

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451

Phase: N/A Priority: Normal
NCT ID: NCT01196676 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance

Phase: N/A Priority: Normal
NCT ID: NCT06726720 Org: User:
Start: 12/16/24 End: 06/30/32 Due: 06/30/33

Study for AZD4360 in Participants With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT06921928 Org: User:
Start: 04/29/25 End: 11/17/27 Due: 11/17/28

Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069

Phase: N/A Priority: Normal
NCT ID: NCT01890148 Org: User:
Start: 03/31/14 End: 08/31/14 Due: 08/31/15

OPTIMISE-CKD Drug Utilization

Phase: N/A Priority: Normal
NCT ID: NCT05932901 Org: User:
Start: 05/04/22 End: 09/28/23 Due: 09/28/24

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01294436 Org: User:
Start: 02/28/11 End: 09/30/12 Due: 09/30/13

An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01146392 Org: User:
Start: 06/30/10 End: 09/30/11 Due: 09/30/12

AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00454805 Org: User:
Start: 03/31/07 End: 04/30/16 Due: 04/30/17